Jan A. Nowak

PhD, MD
Pathology

Specializing In:

Anatomic pathology Clinical pathology Molecular pathology Laboratory management Laboratory regulatory oversight Laboratory and professional services coding and reimbursement

About Jan A. Nowak

Positions

Roswell Park Comprehensive Cancer Center
  • Professor of Oncology
  • Clinical Chief of Molecular Pathology

Background

Education and Training:

  • 1984 - MD - University of Rochester School of Medicine, Rochester, NY
  • 1978 - PhD - Biophysics - University of Rochester, Rochester, NY

Residency:

  • 1988 - Anatomic and Clinical Pathology – Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY

Board Certification:

  • 2003 - Molecular Genetic Pathology, American Board of Pathology
  • 2003 - Molecular Genetic Pathology, American Board of Medical Genetics
  • 1988 - Anatomic and Clinical Pathology, American Board of Pathology
  • NYS Certificate of Qualification (Bacteriology, Cytopathology, Genetic Testing, Histopathology, Mycobacteriology, Oncology, Parasitology, and Virology)

Professional Memberships:

  • College of American Pathologists
  • American Medical Association
  • American Society of Clinical Pathologists
  • United States and Canadian Academy of Pathology
  • American Society of Clinical Oncology (ASCO)
  • Association for Molecular Pathology - Past president
  • Former member, AMA CPT Editorial Panel
  • Co-chair, Molecular Pathology Advisory Group (MPAG)
  • Member, College of American Pathologists Economic Affairs Committee
  • Chair, CPT-RUC Sub Committee
  • Member, Association for Molecular Pathology Economic Affairs Committee

Professional Experience:

  • 2008-2015 - Medical Director - Molecular Diagnostics Laboratory, NorthShore University HealthSystem, Evanston, IL
  • 2005-2008 - Medical Director - ACL Illinois Central Laboratory, ACL Laboratories, Rosemont, IL

Honors & Awards:

  • 2017 – College of American Pathologists, Council on Scientific Affairs Award
  • 2013 - Association for Molecular Pathology Leadership Award

Publications

  • Nowak, JA and Sireci, A, Regulatory and reimbursement issues related to genomic services, In Genomic Applications in Pathology, Netto GE and Kaul, K (eds), 2018, Springer, NY.
  • Lindeman NI, et al., Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology, J Thorac Oncol. 2018 Mar;13(3):323-358. doi: 10.1016/j.jtho.2017.12.001. Epub 2018 Jan 25. PMID:29396253
  • Sepulveda AR, et al, Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology, J Clin Oncol. 2017 May 1;35(13):1453-1486. doi: 10.1200/JCO.2016.71.9807. Epub 2017 Feb 6. PMID: 28165299
  • Fitzgibbons PL, et al, Analytic Validation of Immunohistochemical Assays: A Comparison of Laboratory Practices Before and After Introduction of an Evidence-Based Guideline, Arch Pathol Lab Med. 2017 Sep;141(9):1247-1254. doi: 10.5858/arpa.2016-0558-CP. Epub 2017 May 30. PMID: 28557617
  • Stuart LN, et al, Analytic Validation of Immunohistochemistry Assays: New Benchmark Data From a Survey of 1085 Laboratories, Arch Pathol Lab Med. 2017 Sep;141(9):1255-1261. doi: 10.5858/arpa.2016-0559-CP. Epub 2017 May 30. PMID: 28557616